Sugi Predict

Sugi Predict / Compounds / SCHEMBL1361232

SCHEMBL1361232

SCHEMBL1361232

CC(C)CC(C(=O)N1C(=O)OCC1Cc1ccccc1)C(N)OCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 1/20 0.41
▸ IL6ST P40189 1/20 0.41
▸ FAAH O00519 1/20 0.38
▸ AVPR1A P37288 1/20 0.36
▸ IDH1 O75874 7/20 0.36
▸ CSNK2B P67870 1/20 0.36
▸ CSNK2A1 P68400 1/20 0.36
▸ NAAA Q02083 1/20 0.36
▸ CTSL P07711 2/20 0.35
▸ CTSS P25774 2/20 0.35
▸ CTSK P43235 2/20 0.35
▸ CTSB P07858 1/20 0.35
▸ CAPN1 P07384 1/20 0.35
▸ CACNA1B Q00975 1/20 0.34
▸ SLC1A3 P43003 2/20 0.34
▸ SLC1A2 P43004 2/20 0.34
▸ SLC1A1 P43005 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7081911 0.83 PPARA (0.44) PPARAIL6STFAAHAVPR1AIDH1
SCHEMBL15925281 0.81 IL6ST (0.46) PPARAIL6STFAAHIDH1CSNK2B
SCHEMBL15925295 0.81 IL6ST (0.46) PPARAIL6STFAAHIDH1CSNK2B
SCHEMBL7084082 0.81 PPARA (0.39) PPARAIL6STFAAHAVPR1AIDH1
SCHEMBL7639105 0.80 PPARA (0.46) PPARAIL6STFAAHAVPR1AIDH1
SCHEMBL3782695 0.80 PPARA (0.43) PPARAIL6STFAAHIDH1CSNK2B
SCHEMBL3782697 0.80 PPARA (0.43) PPARAIL6STFAAHIDH1CSNK2B
SCHEMBL6671341 0.80 PPARA (0.43) PPARAIL6STFAAHIDH1CSNK2B
SCHEMBL21153769 0.78 PPARA (0.49) PPARAIL6STFAAHIDH1CSNK2B
SCHEMBL5065686 0.78 PPARA (0.49) PPARAIL6STFAAHIDH1CSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8309579-B2 N-hydroxyamide derivatives and use thereof MERCK SERONO SA (CH) 2012-11-13 — — US disclosed
US-20110281891-A1 N-HYDROXYAMIDE DERIVATIVES AND USE THEREOF MERCK SERONO SA (CH) 2011-11-17 — — US disclosed
EP-1951687-B1 N-HYDROXYAMIDE DERIVATIVES AND USE THEREOF MERCK SERONO SA (CH) 2011-08-24 — — EP disclosed
US-7998964-B2 hydroxy((2S)-2-{[4-(4-methoxyphenyl)piperazin-1-yl]carbonyl}-4-methylpentyl)formamide ; for treatment and/or prevention of disorders related to autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative disorders, stroke, cancer, pre-term labor, endometriosis MERCK SERONO S.A. (CH) 2011-08-16 — — US disclosed
US-20080275060-A1 N-Hydroxyamide Derivatives and Use Thereof LABORATOIRES SERONO SA (CH) 2008-11-06 — — US disclosed
EP-1951687-A1 N-HYDROXYAMIDE DERIVATIVES AND USE THEREOF Laboratoires Serono SA (CH) 2008-08-06 — — EP disclosed
WO-2007060132-A1 N-HYDROXYAMIDE DERIVATIVES AND USE THEREOF LABORATOIRES SERONO S.A. (CH) 2007-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281891-A1 N-HYDROXYAMIDE DERIVATIVES AND USE THEREOF HNMT, HCAR2, HPGD PPARA 721/4885IL6ST 3065/4885FAAH 88/4885
US-20080275060-A1 N-Hydroxyamide Derivatives and Use Thereof HNMT, HCAR2, HPGD PPARA 721/4885IL6ST 3065/4885FAAH 88/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.